跳至主要内容
临床试验/ITMCTR1900002649
ITMCTR1900002649招募中未知

Establishment of a strategy system for the treatment of prostate cancer with Chinese medicine and its superiority research program

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

性别
Male

入选标准

  • (1) Comply with the diagnostic criteria for prostate adenocarcinoma and give endocrine therapy;
  • (2) Serum testosterone <50 ng / dl (1.7 nmol / L);
  • (3) The physical strength of the study subjects is normal, and the karnofsky score exceeds 60 points, and is expected to survive for more than half a year;
  • (4) Patient compliance is good and follow-up studies are possible;
  • (5) Understand and sign the informed consent form.
  • The above five conditions must be met at the same time.

排除标准

  • (1) Patients with serious complications of prostate cancer;
  • (2) Allergic to endocrine therapy drugs;
  • (3) At the same time, it has obvious heart, brain and liver diseases;
  • (4) Patients with primary malignant tumors of organs other than prostate cancer;
  • (5) It is the end stage of the tumor, multiple organ failure.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验